Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01036282
Other study ID # 03I/C14
Secondary ID
Status Completed
Phase Phase 4
First received December 18, 2009
Last updated July 18, 2017
Start date February 2003
Est. completion date December 2016

Study information

Verified date July 2017
Source Nathan Kline Institute for Psychiatric Research
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study is designed to evaluate the effectiveness of computerized cognitive skills training for improving memory and problem-solving skills in inpatients with schizophrenia.


Description:

Subjects are stable inpatients and outpatients with schizophrenia or schizoaffective disorder who are receiving atipsychotic medication at Manhattan Psychiatric Center.

Patients receive baseline assessments (MCCB-MATRICS; Personal and Social Performance Scale, FEDT/FEIT and PANSS) and then are assigned to Cognitive Remediation (CRT) using the COGPACK program, patients are then randomly assigned to a social cognition program (Mind Reader Interactive Guide to Emotions) for a period of 12 weeks. Following 12 weeks of treatment in either CRT + Mind Reader or CRT alone, assessments are repeated by raters.

Cognitive Remediation (CRT): CRT (COGPACK, Marker and Olbrich, 1998) consists of computerized practice tests for seven cognitive domains. There are 64 programs for testing and training, each with several variants for the domains of visuomotor skills, comprehension, reaction, vigilance, memory, language, and intellectual skills. Exercises in COGPACK can be edited and expanded. Patients attend 2 (45-minutes each) groups and 1 discussion group.

Social Cognition Training: Mind Reader (Baron-Cohen et al, 2004) is an interactive computerized program of emotions and mental states. It is based on a taxonomic system of 412 emotions and mental states, grouped into 24 emotion groups, and six developmental levels (from age 4 to adulthood). The emotions and mental states are organized systematically, according to the emotion groups and developmental levels. Patients assigned to Mind Reader attend 1 group per week.

Both the CRT and Mind Reader are administered in small groups of six to eight patients each.


Recruitment information / eligibility

Status Completed
Enrollment 448
Est. completion date December 2016
Est. primary completion date December 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

1. Age 18 and above;

2. In- and out-patients;

3. DSM-IV diagnosis of schizophrenia (all subtypes) or schizoaffective disorder with illness duration >5 years;

4. Auditory and visual acuity adequate to complete cognitive tests;

5. Stable dose of oral atypical antipsychotic for at least 4 weeks;

6. Total PANSS score > 60;

7. Good physical health determined by physical examination from medical chart review;

8. Capacity and willingness to give written informed consent.

9. MMSE > 24

Exclusion Criteria:

1. Inability to read or speak English;

2. Documented disease of the central nervous system;

3. History of intellectual impairment pre-dating onset of symptoms of psychosis (e.g. mental retardation);

4. Clinically significant or unstable cardiovascular, renal, hepatic, gastrointestinal, pulmonary or hematological conditions;

5. HIV +;

6. Patients diagnosed with substance dependence;

7. Currently participating in another experimental study.

Study Design


Intervention

Behavioral:
Computerized Cognitive Skill Training
Behavioral: Cognitive Remediation 45 mins 2 times per week sessions of cognitive remediation (COGPACK) over twelve weeks.
CRT and Social Cognition
Mind Reading, The Interactive Guide to Emotions for one 45 minute session per week for 12 weeks.

Locations

Country Name City State
United States Manhattan Psychiatric Center New York New York

Sponsors (2)

Lead Sponsor Collaborator
Nathan Kline Institute for Psychiatric Research Manhattan Psychiatric Center

Country where clinical trial is conducted

United States, 

References & Publications (1)

Lindenmayer JP, McGurk SR, Mueser KT, Khan A, Wance D, Hoffman L, Wolfe R, Xie H. A randomized controlled trial of cognitive remediation among inpatients with persistent mental illness. Psychiatr Serv. 2008 Mar;59(3):241-7. doi: 10.1176/appi.ps.59.3.241. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Comprehensive battery of neuro-cognitive tests Week 0, and Week 12 (after completion of Cognitive Remediation)
Secondary Facial Emotional Discrimination Task (FEDT) and Facial Emotional Identification Task (FEIT) Test of facial emotion presentations on pictures to patients Week 0, and Week 12 (after compeltion of Cognitive Remediation)
Secondary Personal and Social Performance Scale (PSP) Social function scale with four sub domains of social functioning Week 0, and Week 12 after completion of Cognitive Remediation
Secondary Positive and Negative Syndrome Scale (PANSS) 30 item Gold standard for measurement of psychiatric symptoms Week 0, Week 6 (Midpoint) and Week 12 after completion of Cognitive Remediation
See also
  Status Clinical Trial Phase
Recruiting NCT05039489 - A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia N/A
Completed NCT05321602 - Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder Phase 1
Completed NCT05111548 - Brain Stimulation and Cognitive Training - Efficacy N/A
Completed NCT04503954 - Efficacy of Chronic Disease Self-management Program in People With Schizophrenia N/A
Completed NCT02831231 - Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium Phase 1
Completed NCT05517460 - The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center N/A
Completed NCT03652974 - Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy Phase 4
Recruiting NCT04012684 - rTMS on Mismatch Negativity of Schizophrenia N/A
Recruiting NCT04481217 - Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia N/A
Completed NCT00212784 - Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935) Phase 3
Completed NCT04092686 - A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia Phase 3
Completed NCT01914393 - Pediatric Open-Label Extension Study Phase 3
Recruiting NCT03790345 - Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics Phase 2/Phase 3
Recruiting NCT05956327 - Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training N/A
Terminated NCT03209778 - Involuntary Memories Investigation in Schizophrenia N/A
Terminated NCT03261817 - A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders N/A
Completed NCT02905604 - Magnetic Stimulation of the Brain in Schizophrenia or Depression N/A
Recruiting NCT05542212 - Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia N/A
Completed NCT04411979 - Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia N/A
Terminated NCT03220438 - TMS Enhancement of Visual Plasticity in Schizophrenia N/A